Brazilian cancer care provider Oncoclínicas reported positive EBITDA in the second quarter of 2026, despite a decline in revenue, according to slides released on Monday.
The company’s adjusted EBITDA for the quarter turned positive, reflecting improved operational efficiency amid a challenging revenue environment. Oncoclínicas did not provide specific numerical figures in the slides, but noted that revenue fell year-over-year.
The positive EBITDA milestone follows a period of cost optimization and restructuring efforts aimed at enhancing profitability. Oncoclínicas has been focusing on streamlining operations and leveraging scale to offset revenue pressures in Brazil’s healthcare sector.
Analysts will scrutinize the company’s ability to sustain positive EBITDA as it navigates macroeconomic headwinds, including inflation and regulatory pressures in the Brazilian market. Oncoclínicas operates a network of cancer treatment centers across Brazil, positioning itself as a key player in the country’s growing oncology market.
